Replies to post #15938 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

MNTA wants to keep the latest amendment to the collaboration agreement with NVS redacted—this is the SEC document in question:

https://www.sec.gov/Archives/edgar/data/1235010/000123501016000008/mnta06302016ex101redacteda.htm

MNTA's request to main confidential treatment is routine.